May Barnhard Investments LLC Invests $440,000 in UnitedHealth Group Incorporated (NYSE:UNH)

May Barnhard Investments LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 869 shares of the healthcare conglomerate’s stock, valued at approximately $440,000.

Several other large investors have also made changes to their positions in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $30,000. Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the 3rd quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $40,000. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Stephens raised their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 0.1 %

NYSE UNH opened at $480.79 on Friday. The business has a fifty day simple moving average of $511.85 and a 200 day simple moving average of $551.01. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market capitalization of $439.78 billion, a P/E ratio of 31.02, a PEG ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm posted $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.75%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.